Laffer Tengler Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,521
| Closed | -$154K | – | 302 |
|
|
2024
Q2 | $154K | Buy |
5,521
+2
| +0% | +$55 | 0.03% | 184 |
|
|
2024
Q1 | $153K | Sell |
5,519
-71
| -1% | -$1.97K | 0.04% | 164 |
|
|
2023
Q4 | $161K | Buy |
5,590
+164
| +3% | +$4.96K | 0.04% | 158 |
|
|
2023
Q3 | $180K | Hold |
5,426
| – | – | 0.05% | 146 |
|
|
2023
Q2 | $199K | Sell |
5,426
-349
| -6% | -$13.6K | 0.05% | 200 |
|
|
2023
Q1 | $236K | Sell |
5,775
-1,979
| -26% | -$85.5K | 0.06% | 186 |
|
|
2022
Q4 | $397K | Buy |
7,754
+201
| +3% | +$9.64K | 0.11% | 153 |
|
|
2022
Q3 | $331K | Hold |
7,553
| – | – | 0.12% | 144 |
|
|
2022
Q2 | $396K | Buy |
7,553
+1
| +0% | +$51 | 0.14% | 137 |
|
|
2022
Q1 | $391K | Hold |
7,552
| – | – | 0.12% | 149 |
|
|
2021
Q4 | $446K | Buy |
7,552
+1
| +0% | +$50 | 0.13% | 142 |
|
|
2021
Q3 | $325K | Buy |
+7,551
| New | +$335K | 0.09% | 168 |
|
|
2021
Q2 | – | Sell |
-6,226
| Closed | -$226K | – | 380 |
|
|
2021
Q1 | $226K | Buy |
6,226
+800
| +15% | +$28.4K | 0.09% | 145 |
|
|
2020
Q4 | $199K | Sell |
5,426
-293
| -5% | -$10.7K | 0.08% | 154 |
|
|
2020
Q3 | $199K | Buy |
5,719
+3,853
| +206% | +$135K | 0.1% | 139 |
|
|
2020
Q2 | $57.9K | Buy |
+1,866
| New | +$63.4K | 0.03% | 193 |
|
|
2019
Q1 | – | Sell |
-18,635
| Closed | -$772K | – | 191 |
|
|
2018
Q4 | $772K | Sell |
18,635
-205
| -1% | -$8.51K | 0.23% | 135 |
|
|
2018
Q3 | $788K | Sell |
18,840
-1,043
| -5% | -$40.2K | 0.2% | 143 |
|
|
2018
Q2 | $684K | Sell |
19,883
-527
| -3% | -$18K | 0.18% | 150 |
|
|
2018
Q1 | $687K | Buy |
20,410
+151
| +0.7% | +$5.19K | 0.17% | 147 |
|
|
2017
Q4 | $696K | Sell |
20,259
-1,899
| -9% | -$64.8K | 0.17% | 164 |
|
|
2017
Q3 | $751K | Sell |
22,158
-729
| -3% | -$23.4K | 0.2% | 161 |
|
|
2017
Q2 | $729K | Sell |
22,887
-65
| -0.3% | -$2.05K | 0.19% | 170 |
|
|
2017
Q1 | $745K | Sell |
22,952
-4,583
| -17% | -$144K | 0.2% | 169 |
|
|
2016
Q4 | $849K | Sell |
27,535
-112,394
| -80% | -$3.43M | 0.23% | 173 |
|
|
2016
Q3 | $4.5M | Buy |
139,929
+1,336
| +1% | +$44.7K | 1.25% | 9 |
|
|
2016
Q2 | $4.63M | Buy |
138,593
+117,380
| +553% | +$3.75M | 1.32% | 8 |
|
|
2016
Q1 | $597K | Buy |
+21,213
| New | +$606K | 0.16% | 178 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 175 |
|
|
2015
Q3 | – | Sell |
-59,666
| Closed | -$1.91M | – | 150 |
|
|
2015
Q2 | $1.9M | Sell |
59,666
-323,171
| -84% | -$10.5M | 0.46% | 73 |
|
|
2015
Q1 | $12.6M | Buy |
+382,837
| New | +$12.2M | 1.77% | 17 |
|
|
2013
Q3 | – | Sell |
-113,864
| Closed | -$3.03M | – | 283 |
|
|
2013
Q2 | $3.03M | Buy |
+113,864
| New | +$3.15M | 0.59% | 61 |
|
Other funds holding PFE
Laffer Tengler Investments's PFE Position: Q3 2024 in Review
Laffer Tengler Investments sold out of Pfizer (PFE) in Q3 2024, closing a stake of 5,521 shares — an estimated $154K sold.
Laffer Tengler Investments first reported a position in PFE in Q2 2013 and held it in 31 quarters. The position peaked at $12.6M in Q1 2015. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Laffer Tengler Investments reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- Laffer Tengler Investments sold 5,521 Pfizer shares in Q3 2024, an estimated $154K.
- Laffer Tengler Investments first reported a position in Pfizer in Q2 2013 and held it in 31 quarters.
- Laffer Tengler Investments's Pfizer position peaked at $12.6M in Q1 2015.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Laffer Tengler Investments's 13F filing for Q3 2024, filed 4 Nov 2024.